{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Pyelonephritis in Pregnancy

Activity Steps

Description

NOTE: Individual subscribers will be required to submit payment before viewing. Users accessing via an institutional subscription can proceed without payment.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Explain criteria for diagnosis, risk factors, and preventive modalities for pyelonephritis in pregnancy.
  2. Describe maternal and fetal sequelae of pyelonephritis in pregnancy.
  3. Summarize treatment protocols for pyelonephritis in stable and unstable patients.
Price: $49.00

Credits:

  • ANCC 2.0 CH / 1.0 APH
  • DC - BON 2.0 CH
  • FL - BON 2.0 CH
  • GA - BON 2.0 CH

Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.

Awarded Advanced Pharmacology Hours







Test Code: PGO0122A
Published: January 15, 2022
Expires: 12/6/2024
Required Passing Score: 8/10 (80%)
Authors: Alice Trye, BS; Kaila Krishnamoorthy, MD; Lisa N. Gittens-Williams, MD